Giulia Bertoli

Dr. Giulia Bertoli

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
ZBZeno Bisoffi
Zeno Bisoffi
EPE. Pomari
E. Pomari
MDMichela Deiana
Michela Deiana
CPChiara Piubelli
Chiara Piubelli
NRNiccolò Ronzoni
Niccolò Ronzoni
Ronaldo SilvaRonaldo Silva
Ronaldo Silva
Background: We assessed the sensitivity, specificity and positive and negative predictive value (PPV and NPV) of molecular and serological tests for the diagnosis of SARS-CoV-2 infection. Methods: A total of 346 patients were enrolled in the emergency room. We evaluated three Reverse Transcriptase-real time PCRs (RT-PCRs) including six different gene targets, five serologic rapid diagnostic tests (RDT) and one ELISA. The final classification of infected/non-infected patients was performed using Latent Class Analysis combined with clinical re-assessment of incongruous cases. Results: Out of these, 24.6% of patients were classified as infected. The molecular test RQ-SARS-nCoV-2 showed the highest performance with 91.8% sensitivity, 100% specificity, 100.0% PPV and 97.4% NPV respectively. Considering the single gene targets, S and RdRp of RQ-SARS-nCoV-2 had the highest sensitivity (94.1%). The in-house RdRp presented the lowest sensitivity (62.4%). The specificity ranged from 99.2% for in-house RdRp and N2 to 95.0% for E. The PPV ranged from 97.1% of N2 to 85.4% of E and the NPV from 98.1% of S to 89.0% of in-house RdRp. All serological tests had < 50% sensitivity and low PPV and NPV. VivaDiag IgM (RDT) had 98.5% specificity, with 84.0% PPV, but 24.7% sensitivity. Conclusion: Molecular tests for SARS-CoV-2 infection showed excellent specificity, but significant differences in sensitivity. Serological tests have limited utility in a clinical context.

15 April 2020 in Infection
Verified
Journal Article
Closed access
PDF file
TUTamara Ursini
Tamara Ursini
LMLucia Moro
Lucia Moro
ARAna Requena-Méndez
Ana Requena-Méndez
GBGiulia Bertoli
Giulia Bertoli
Dora BuonfrateDora Buonfrate
Dora Buonfrate

28 June 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
PCPaolo Cattaneo
Paolo Cattaneo
AVAlessandro Volpe
Alessandro Volpe
CCChiara Simona Cardellino
Chiara Simona Cardellino
NRNiccolo Riccardi
Niccolo Riccardi
GBGiulia Bertoli
Giulia Bertoli
AAAndrea Angheben
Andrea Angheben
During the current SARS-CoV-2 pandemic, a novel syndrome termed “multisystem inflammatory syndrome in children” (MIS-C) has emerged. MIS-C was linked to COVID-19 and shared some features with Kawasaki disease and Toxic Shock Syndrome, with a common pathogenetic substrate of hyperinflammation and cytokine storm. Lately, MIS was also described in adults (≥21 years of age) and named “MIS-A”. There is no consensus about the treatment of MIS-A; successful use of glucocorticoids and immunoglobulins has been reported in case series, but more solid evidence is lacking. Furthermore, the role of biologic agents with proven benefits against COVID-19, MIS-C, or Kawasaki disease is still unexplored. In this report, we detail the clinical picture and the diagnostic process that led to the diagnosis of MIS-A in a 27-year-old man, focusing on its treatment with anakinra and glucocorticoids, which resulted in full recovery. To our knowledge, this is the first report of the successful use of anakinra for MIS-A, a drug that has already proven useful in the treatment of refractive cases of MIS-C. Anakinra may also play a pivotal role for the treatment of MIS-A.

26 August 2021 in Tomography
Verified
Journal Article
Open access
PDF file
GFGiovanni Foti
Giovanni Foti
GSGerardo Serra
Gerardo Serra
VIVenanzio Iacono
Venanzio Iacono
Stefania MaroccoStefania Marocco
Stefania Marocco
GBGiulia Bertoli
Giulia Bertoli
CZClaudio Zorzi
Claudio Zorzi
Dual-energy computed tomography (DECT) is an imaging technique widely used in traumatic settings to diagnose bone marrow oedema (BME). This paper describes the role of DECT in diagnosing BME in non-traumatic settings by evaluating its reliability in analyzing some of the most common painful syndromes. In particular, with an illustrative approach, the paper describes the possible use of DECT for the evaluation of osteochondral lesions of the knee and of the ankle, avascular necrosis of the hip, non-traumatic stress fractures, and other inflammatory and infectious disorders of the bones.

13 February 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
GFGiovanni Foti
Giovanni Foti
CLChiara Longo
Chiara Longo
CSClaudia Sorgato
Claudia Sorgato
EOEugenio Simone Oliboni
Eugenio Simone Oliboni
CMCristina Mazzi
Cristina Mazzi
Stefania MaroccoStefania Marocco
Stefania Marocco
Background: MRI is the preferred imaging technique for the identification of osteomyelitis. The key element for diagnosis is the presence of bone marrow edema (BME). Dual-energy CT (DECT) is an alternative tool which is able to identify BME in the lower limb. Purpose: To compare the diagnostic performance of DECT and MRI for osteomyelitis, using clinical, microbiological, and imaging data as reference standards. Materials and Methods: This prospective single-center study enrolled consecutive patients with suspected bone infections undergoing DECT and MRI imaging from December 2020 to June 2022. Four blinded radiologists with various experience levels (range of 3-21 years) evaluated the imaging findings. Osteomyelitis was diagnosed in the presence of BMEs, abscesses, sinus tracts, bone reabsorption, or gaseous elements. The sensitivity, specificity, and AUC values of each method were determined and compared using a multi-reader multi-case analysis. A p value < 0.05 was considered significant. Results: In total, 44 study participants (mean age 62.5 years ± 16.5 [SD], 32 men) were evaluated. Osteomyelitis was diagnosed in 32 participants. For the MRI, the mean sensitivity and specificity were 89.1% and 87.5%, while for the DECT they were 89.0% and 72.9%, respectively. The DECT demonstrated a good diagnostic performance (AUC = 0.88), compared with the MRI (AUC = 0.92) (p = 0.12). When considering each imaging finding alone, the best accuracy was achieved by considering BME (AUC for DECT 0.85 versus AUC of MRI of 0.93, with p = 0.07), followed by the presence of bone erosions (AUC 0.77 for DECT and 0.53 for MRI, with p = 0.02). The inter-reader agreement of the DECT (k = 88) was similar to that of the MRI (k = 90). Conclusion: Dual-energy CT demonstrated a good diagnostic performance in detecting osteomyelitis.

1 March 2021 in Ticks and Tick-borne Diseases
Verified
Journal Article
Open access
ABAnna Beltrame
Anna Beltrame
PRPaola Rodari
Paola Rodari
LMLuisa Mauroner
Luisa Mauroner
ZZZanella Zanella
Zanella Zanella
LMLucia Moro
Lucia Moro
Ronaldo SilvaRonaldo Silva
Ronaldo Silva
We investigated the epidemiology, clinical manifestations, laboratory data and antibiotic treatment of Lyme borreliosis in the province of Verona, Northern Italy, during the period 2015-2019. One hundred and 29 cases of Lyme borreliosis were diagnosed in a single hospital representing 27 % of all cases reported in the Veneto region in the same period. The mean annual incidence of Lyme borreliosis was 0.992/100,000 inhabitants. A peak incidence of 2/100,000 inhabitants was observed in 2018. Early localized Lyme borreliosis was the most common presentation (74 %), followed by early disseminated Lyme borreliosis (21 %). One possible early Lyme neuroborreliosis and two cranial neuropathies were diagnosed. IgM and/or IgG borrelia antibodies were positive in 90 % of the cases. This significant increase of Lyme borreliosis incidence in the province of Verona highlights the need to increase knowledge on its epidemiology and clinical manifestation among both the general population and clinicians to allow early diagnosis and treatment.